purpos
investig
studi
viral
aetiolog
influenzalik
ill
ili
acut
respiratori
tract
infect
arti
among
patient
requir
intens
care
unit
admiss
crosssect
retrospect
studi
carri
sicili
period
total
respiratori
sampl
patient
ili
arti
admit
intens
care
unit
molecularli
analyz
detect
comprehens
panel
aetiolog
agent
viral
respiratori
infect
patient
posit
least
one
pathogen
singl
aetiolog
occur
infect
patient
polymicrobi
infect
found
posit
subject
influenza
common
aetiolog
agent
especi
among
adult
patient
multipl
aetiolog
adult
elderli
mortal
rate
among
patient
neg
posit
aetiolog
significantli
differ
respect
highli
transmiss
respiratori
pathogen
frequent
detect
among
patient
iliarti
admit
intens
care
unit
show
occurr
concurr
infect
differ
virus
knowledg
circul
sever
type
microorgan
crucial
import
term
appropri
therapi
also
implic
prevent
strategi
hospit
epidemiolog
accord
world
health
organ
influenza
viru
acut
respiratori
tract
infect
arti
caus
consider
morbid
mortal
worldwid
repres
close
death
year
age
particularli
develop
countri
moreov
elderli
immunocompromis
subject
influenzalik
ill
ili
arti
higher
risk
exacerb
preexist
chronic
condit
progress
respiratori
complic
respons
hospit
admiss
intens
care
unit
icu
demonstr
sever
pathogen
implic
iliarti
either
viral
bacteri
origin
although
specif
aetiolog
often
goe
undiagnos
patient
acut
respiratori
ill
admit
icu
usual
monitor
follow
standard
approach
consist
routin
cultur
test
bacteri
agent
commonli
respons
communityacquir
pneumonia
convers
viral
agent
gener
underestim
clinic
relev
laboratori
detect
often
use
secondlin
diagnost
limit
patient
neg
bacteri
pathogen
consequ
lead
delay
administr
potenti
benefici
antivir
drug
addit
wellknown
patient
show
acut
febril
respiratori
ill
may
facilit
spread
infecti
agent
especi
earli
phase
diseas
often
sustain
aerosolgener
procedur
abl
favor
patienttopati
dissemin
icu
healthcar
worker
hcw
visitor
ultim
commun
evid
enhanc
well
document
low
vaccin
coverag
rate
among
hcw
versu
influenza
prevent
infecti
respiratori
diseas
well
inappropri
habit
work
symptomat
ili
although
impact
influenza
infect
intens
care
ward
previous
describ
particularli
influenza
pandem
limit
number
studi
focus
complex
aetiolog
iliarti
critic
ill
patient
admit
icu
context
better
understand
wide
spectrum
viral
respiratori
pathogen
caus
acut
infect
among
hospit
patient
set
essenti
improv
prevent
therapeut
strategi
priorit
diagnost
effort
purpos
crosssect
studi
evalu
burden
ili
andor
arti
among
hospit
patient
admit
intens
care
unit
sicili
determin
specif
aetiolog
respiratori
infect
crosssect
retrospect
studi
carri
juli
decemb
differ
biolog
sampl
oropharyng
swab
broncoalveolar
lavag
intub
patient
consecut
collect
patient
admit
intens
care
unit
clinic
symptom
ili
arti
ili
arti
defin
accord
european
centr
diseas
prevent
control
ecdc
http
ecdceuropaeuenhealthtopicsinfluenzasurveillancepag
influenzacasedefinitionsaspx
access
twentytwo
differ
hospit
locat
sicili
italian
region
popul
million
peopl
http
demo
particip
studi
basi
current
nation
healthcar
system
itali
patient
stratifi
three
differ
agegroup
year
year
year
pediatr
adult
elderli
patient
respect
crosslinkag
hospit
discharg
record
hdr
avail
sicilian
region
region
depart
health
epidemiolog
observatori
perform
order
confirm
inform
obtain
addit
epidemiolog
data
concern
intern
classif
diseas
code
length
hospit
stay
death
consequ
studi
popul
consist
patient
admit
icu
iliarti
clinic
symptom
hdr
includ
code
suggest
iliarti
primari
secondari
diagnosi
final
code
set
select
accord
marsdenhaug
colleagu
inclus
code
arti
ie
respiratori
specimen
transport
c
store
c
upon
arriv
process
laboratori
clinic
epidemiolog
unit
univers
hospit
p
giaccon
palermo
sicili
itali
sampl
analys
detect
specif
viral
genom
belong
human
respiratori
syncyti
viru
type
detect
respiratori
pathogen
perform
singleplex
realtim
pcr
rpcr
assay
use
taqman
technolog
run
realtim
pcr
system
platform
appli
biosystem
life
technolog
primer
probe
set
describ
supplementari
tabl
detect
rna
virus
perform
rtrpcr
singl
step
use
superscript
iii
platinum
onestep
quantit
rtpcr
system
invitrogen
life
technolog
dna
virus
platinum
quantit
pcr
supermixudg
rox
invitrogen
life
technolog
use
accord
manufactur
instruct
run
includ
posit
neg
control
target
flua
flub
rtrpcr
assay
wild
type
virus
use
posit
control
wherea
target
plasmid
standard
use
clone
topo
ta
vector
life
technolog
synthet
construct
geneart
gene
synthesi
life
technolog
pcr
product
descript
statist
calcul
explor
burden
iliarti
among
icu
patient
distribut
singl
multipl
aetiolog
gender
age
length
hospit
stay
advers
outcom
categor
variabl
describ
frequenc
percentag
compar
chisquar
test
fisher
exact
test
appropri
continu
variabl
present
median
interquartil
rang
compar
use
student
test
normal
demonstr
otherwis
nonparametr
mannewhitney
u
test
perform
cochranearmitag
test
trend
use
compar
preval
across
differ
subgroup
test
twotail
pvalu
consid
statist
signific
analys
perform
stata
version
macintosh
appl
present
work
review
approv
institut
review
board
univers
hospit
p
giaccon
palermo
health
data
store
accord
italian
law
privaci
research
conduct
follow
helsinki
declar
statement
written
inform
consent
waiv
due
nonintervent
design
schemat
diagram
inclusionexclus
criteria
use
select
studyrefer
popul
depict
fig
accord
hdr
databas
sicili
total
admiss
record
studi
period
n
regular
hospit
admiss
onehalf
n
emerg
depart
ed
whole
icu
hospit
sicili
account
n
total
edrel
admiss
n
includ
code
suggest
iliarti
health
record
period
total
respiratori
sampl
collect
icu
patient
iliarti
patient
retrospect
found
match
inclus
criteria
includ
final
studi
group
therefor
estim
includ
analysi
n
sicilian
hospit
critic
ill
patient
show
iliarti
present
age
rang
day
year
median
year
iqr
year
patient
laboratoryconfirm
viral
aetiolog
significantli
younger
neg
subject
year
vs
year
p
signific
agediffer
group
singl
multipl
infect
year
vs
year
p
respect
although
nonpediatr
subject
cover
iliarti
case
sicili
studi
period
higher
posit
rate
infect
observ
among
younger
individu
proport
posit
subject
significantli
decreas
age
p
length
hospit
stay
differ
neither
neg
posit
patient
p
subject
show
singl
coinfect
p
pneumonia
preval
advers
outcom
n
follow
respiratori
failur
n
acut
respiratori
distress
syndrom
ard
n
sepsi
andor
septic
shock
document
clinic
record
icupati
eightyfour
patient
iliarti
present
deceas
differ
observ
relat
aetiolog
p
vs
death
among
neg
posit
subject
respect
gener
iliarti
case
report
throughout
studi
period
season
influenza
confirm
infect
mainli
detect
period
octoberemarch
differ
viral
aetiolog
also
found
august
septemb
april
may
detail
see
supplementari
fig
supplementari
fig
depict
proport
laboratoryconfirm
sampl
accord
aforement
three
differ
agegroup
microorgan
studi
popul
laboratoryconfirm
posit
stratifi
accord
singl
multipl
detect
tabl
half
subject
monoinfect
n
adult
gener
influenza
virus
common
aetiolog
agent
n
influenza
h
n
prevail
especi
among
adult
n
human
parainfluenza
virus
enterovirus
similar
detect
frequenc
respect
six
patient
infect
human
respiratori
syncyti
virus
four
patient
human
coronavirus
n
n
n
found
final
subject
posit
human
rhinoviru
well
human
bocaviru
type
one
patient
posit
human
ki
polyomaviru
adv
hpev
wupyv
detect
icupati
laboratoryconfirm
polymicrobi
aetiolog
n
adult
elderli
tabl
period
studi
million
hospit
record
sicili
admiss
rate
intens
care
ed
document
area
compar
report
develop
countri
howev
mani
differ
still
remain
high
variabl
threshold
icuadmiss
respect
intens
care
servic
provid
differ
healthcar
system
clinic
manag
strategi
critic
ill
patient
resourc
ultim
avail
icu
bed
date
respiratori
infect
still
repres
major
concern
lead
caus
hospit
admiss
intens
care
although
burden
aetiolog
influenza
like
ill
acut
respiratori
infect
yet
welldefin
key
find
present
studi
viral
infect
affect
larg
proport
icu
patient
ili
arti
detect
rate
studi
popul
significantli
higher
previous
report
european
countri
accord
author
influenza
viru
frequent
detect
microorgan
coincid
detect
differ
viral
pathogen
constitut
total
infect
fit
well
result
similar
report
regard
lower
detect
rate
found
differ
set
nonicu
hospit
patient
potenti
synerg
virus
bacteria
lead
sever
diseas
excess
mortal
underlin
import
complet
microbiolog
investig
particularli
group
sever
ill
patient
higher
risk
death
respiratori
pathogen
found
seri
human
parainfluenza
virus
coronavirus
respect
also
describ
caus
signific
symptom
morbid
potenti
need
intens
care
treatment
surprisingli
microorgan
hrv
hrsv
hmpv
commonli
report
sever
studi
also
respons
admiss
icu
mortal
elderli
found
low
preval
often
codetect
respiratori
agent
tabl
distribut
singl
multipl
aetiolog
b
among
icu
hospit
patient
sicili
present
iliarti
accord
agegroup
period
juli
decemb
scenario
regardless
frequenc
detect
differ
infecti
agent
knowledg
circul
sever
type
microorgan
may
essenti
standpoint
infect
prevent
hospit
epidemiolog
even
crucial
intens
care
ward
fact
differ
situat
may
respons
healthcar
facil
outbreak
highli
transmiss
respiratori
pathogen
one
hand
lack
appropri
isol
strategi
high
vulner
patient
acut
febril
respiratori
ill
prior
diagnosi
potenti
infecti
agent
hand
low
complianc
vaccin
coverag
rate
among
hcw
worsen
improp
behaviour
presente
work
ill
rather
take
sick
leav
preval
among
hcw
despit
recent
recommend
center
diseas
control
prevent
prevent
strategi
ili
healthcar
set
awar
limit
studi
first
descript
retrospect
studi
comparison
group
differ
risk
consid
order
evalu
potenti
role
singlemultipl
aetiolog
caus
icu
hospit
sever
diseas
second
lack
data
regard
bacteri
aetiolog
allow
detail
copres
bacterialvir
infect
consequ
caus
underestim
infect
rate
icupati
third
set
oropharyng
sampl
mostli
collect
like
repres
microbiota
upper
airway
unabl
distinguish
colon
infect
upper
respiratori
tract
infect
lower
airway
despit
hypothes
agreement
lower
upper
respiratori
specimen
detect
respiratori
pathogen
difficult
formul
assumpt
case
pathogen
detect
microorgan
upper
respiratori
tract
anatom
site
reservoir
divers
commun
commens
germ
dynam
process
individu
risk
factor
imbal
ecosystem
may
chang
role
pathogen
caus
respiratori
invas
diseas
also
immunocompet
subject
furthermor
immunosuppress
subject
elderli
may
suffer
preexist
respiratori
tract
involv
pulmonari
cardiac
failur
togeth
low
vaccin
coverag
rate
lead
hospit
intens
care
treatment
nevertheless
despit
limit
present
studi
includ
good
repres
geograph
area
although
moder
sampl
size
use
comprehens
panel
microorgan
addit
studi
differ
previou
publish
report
popul
studi
also
includ
ili
subject
rather
patient
pneumonia
sever
respiratori
symptom
thu
depict
heterogen
respiratori
agent
circul
intens
care
set
find
confirm
polymicrobi
aetiolog
common
among
patient
iliarti
admit
icu
play
import
role
overal
outcom
vulner
patient
repres
unrecogn
health
exposur
put
icuadmit
patient
risk
earli
recognit
iliarti
aetiolog
icu
import
order
implement
earli
infectioncontrol
strategi
assess
drug
therapi
appropri
approach
critic
ill
patient
respiratori
symptom
need
evolv
includ
public
health
perspect
also
promot
posit
habit
among
hcw
addit
focu
individu
diagnosi
treatment
author
report
conflict
interest
relev
articl
